SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Inrad Optics, Inc. – ‘10-Q’ for 9/30/23 – ‘EX-31.2’

On:  Tuesday, 11/14/23, at 8:13am ET   ·   For:  9/30/23   ·   Accession #:  1410578-23-2447   ·   File #:  0-11668

Previous ‘10-Q’:  ‘10-Q’ on 8/11/23 for 6/30/23   ·   Latest ‘10-Q’:  This Filing   ·   1 Reference:  By:  Inrad Optics, Inc. – ‘10-K’ on 3/28/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/14/23  Inrad Optics, Inc.                10-Q        9/30/23   51:4.8M                                   Toppan Merrill/FA2

Quarterly Report   —   Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.06M 
 2: EX-4.1      Instrument Defining the Rights of Security Holders  HTML     39K 
 3: EX-4.2      Instrument Defining the Rights of Security Holders  HTML     39K 
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     21K 
 5: EX-31.2     Certification -- §302 - SOA'02                      HTML     22K 
 6: EX-32.1     Certification -- §906 - SOA'02                      HTML     18K 
 7: EX-32.2     Certification -- §906 - SOA'02                      HTML     18K 
13: R1          Document and Entity Information                     HTML     68K 
14: R2          Condensed Consolidated Balance Sheets               HTML    118K 
15: R3          Condensed Consolidated Balance Sheets               HTML     27K 
                (Parenthetical)                                                  
16: R4          Condensed Consolidated Statements of Operations     HTML     81K 
                (Unaudited)                                                      
17: R5          Condensed Consolidated Statements of Shareholders'  HTML     74K 
                Equity                                                           
18: R6          Condensed Consolidated Statements of Cash Flows     HTML     92K 
19: R7          Summary of Significant Accounting Policies          HTML    139K 
20: R8          Concentration of Cash                               HTML     19K 
21: R9          Revenue                                             HTML     50K 
22: R10         Equity Compensation Program and Stock Based         HTML     99K 
                Compensation                                                     
23: R11         Stockholders' Equity                                HTML     23K 
24: R12         Related Party Transactions                          HTML     22K 
25: R13         Other Long-Term Notes                               HTML     34K 
26: R14         Lease Amendment                                     HTML     19K 
27: R15         Summary of Significant Accounting Policies          HTML    163K 
                (Policies)                                                       
28: R16         Summary of Significant Accounting Policies          HTML    130K 
                (Tables)                                                         
29: R17         Revenue (Tables)                                    HTML     43K 
30: R18         Equity Compensation Program and Stock Based         HTML    102K 
                Compensation (Tables)                                            
31: R19         Other Long-Term Notes (Tables)                      HTML     33K 
32: R20         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     24K 
                Inventories (Details)                                            
33: R21         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Basic  HTML     77K 
                and diluted earnings (Loss) Per Common Share                     
                (Details)                                                        
34: R22         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     41K 
                Additional Information (Details)                                 
35: R23         Concentration of Cash (Details)                     HTML     21K 
36: R24         REVENUE - Company's sales by market area (Details)  HTML     36K 
37: R25         REVENUE - Additional Information (Details)          HTML     40K 
38: R26         Equity Compensation Program and Stock Based         HTML     41K 
                Compensation (Details)                                           
39: R27         Equity Compensation Program and Stock Based         HTML     26K 
                Compensation - Weighted-average assumptions                      
                (Details)                                                        
40: R28         EQUITY COMPENSATION PROGRAM AND STOCK BASED         HTML     63K 
                COMPENSATION- Stock option activity (Details)                    
41: R29         EQUITY COMPENSATION PROGRAM AND STOCK BASED         HTML     33K 
                COMPENSATION - Non-vested stock option activity                  
                (Details)                                                        
42: R30         Stockholders' Equity (Details)                      HTML     20K 
43: R31         Related Party Transactions (Details)                HTML     39K 
44: R32         Other Long-Term Notes (Details)                     HTML     29K 
45: R33         Other Long-Term Notes - Additional information      HTML     38K 
                (Details)                                                        
46: R34         Lease Amendment (Details)                           HTML     23K 
49: XML         IDEA XML File -- Filing Summary                      XML     81K 
47: XML         XBRL Instance -- inrd-20230930x10q_htm               XML   1.29M 
48: EXCEL       IDEA Workbook of Financial Report Info              XLSX     73K 
 9: EX-101.CAL  XBRL Calculations -- inrd-20230930_cal               XML     91K 
10: EX-101.DEF  XBRL Definitions -- inrd-20230930_def                XML    237K 
11: EX-101.LAB  XBRL Labels -- inrd-20230930_lab                     XML    678K 
12: EX-101.PRE  XBRL Presentations -- inrd-20230930_pre              XML    492K 
 8: EX-101.SCH  XBRL Schema -- inrd-20230930                         XSD     88K 
50: JSON        XBRL Instance as JSON Data -- MetaLinks              278±   420K 
51: ZIP         XBRL Zipped Folder -- 0001410578-23-002447-xbrl      Zip    203K 


‘EX-31.2’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:  <!  <> 

Exhibit 31.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Theresa A. Balog certify that:

1.

I have reviewed the quarterly report on Form 10-Q of Inrad Optics, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e) and internal control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d -15(f)) for the registrants and have:

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations; and

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function(s):

a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Dated:

November 14, 2023

/s/ Theresa A. Balog

Chief Financial Officer,

Secretary and Treasurer

A signed original of this written statement required by Section 302 has been provided to Inrad Optics, Inc. and will be retained by Inrad Optics, Inc. and furnished to the Securities Exchange Commission or its staff upon request.



Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:11/14/23None on these Dates
For Period end:9/30/23
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/28/24  Inrad Optics, Inc.                10-K       12/31/23   75:6M                                     Toppan Merrill/FA2
Top
Filing Submission 0001410578-23-002447   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 1:26:01.1am ET